Opioid Use Disorder Market Size, Share, Forecast Report 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Opioid Use Disorder Market, 2024 - 2032, (USD Billion)
  • 2.2. Opioid Use Disorder Market: Snapshot
• Chapter 3. Global Opioid Use Disorder Market - Industry Analysis
  • 3.1. Opioid Use Disorder Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Rising opioid use
  • 3.3. Restraints
    • 3.3.1. Regulatory stringency
  • 3.4. Opportunity
    • 3.4.1. Government funding and support
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by Drug Segment
    • 3.6.2. Market attractiveness analysis by regional segment
• Chapter 4. Global Opioid Use Disorder Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Opioid Use Disorder market: company market share analysis, 2024
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New product launches
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
• Chapter 5. Global Opioid Use Disorder Market - Product Segment Analysis
  • 5.1. Global Opioid Use Disorder market overview: by Product
    • 5.1.1. Global Opioid Use Disorder market revenue share, by Product, 2024 and 2032
  • 5.2. Buprenorphine
    • 5.2.1. Global Opioid Use Disorder market by Buprenorphine, 2024-2032 (USD Billion)
    • 5.2.2. Bunavail
      • 5.2.2.1. Global Opioid Use Disorder market by Bunavail, 2024-2032 (USD Billion)
    • 5.2.3. Sublocade
      • 5.2.3.1. Global Opioid Use Disorder market by Sublocade, 2024-2032 (USD Billion)
    • 5.2.4. Suboxone
      • 5.2.4.1. Global Opioid Use Disorder market by Suboxone, 2024-2032 (USD Billion)
    • 5.2.5. Zubsolv
      • 5.2.5.1. Global Opioid Use Disorder market by Zubsolv, 2024-2032 (USD Billion)
    • 5.2.6. Others
      • 5.2.6.1. Global Opioid Use Disorder market by Others, 2024-2032 (USD Billion)
  • 5.3. Methadone
    • 5.3.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2024-2032 (USD Billion)
  • 5.4. Naltrexone
    • 5.4.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2024-2032 (USD Billion)
• Chapter 6. Global Opioid Use Disorder Market - Regional Analysis
  • 6.1. Global Opioid Use Disorder market overview: by region
    • 6.1.1. Global Opioid Use Disorder market revenue share, by region, 2024 and 2032
  • 6.2. North America
    • 6.2.1. North America Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
    • 6.2.2. North America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.2.3. The U.S.
      • 6.2.3.1. The U.S. Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.2.4. Rest of North America
      • 6.2.4.1. Rest of North America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
    • 6.3.2. Europe Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.3.3. U.K.
      • 6.3.3.1. U.K. Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. France Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.3.5. Germany
      • 6.3.5.1. Germany Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.3.6. Rest of Europe
      • 6.3.6.1. Rest of Europe Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
    • 6.4.2. Asia Pacific Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.4.3. China
      • 6.4.3.1. China Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.4.4. Japan
      • 6.4.4.1. Japan Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. India Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.4.6. Rest of Asia Pacific
      • 6.4.6.1. Rest of Asia Pacific Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
    • 6.5.2. Latin America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.5.3. Brazil
      • 6.5.3.1. Brazil Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.5.4. Rest of Latin America
      • 6.5.4.1. Rest of Latin America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa Opioid Use Disorder market, 2024-2032 (USD Billion)
    • 6.6.2. Middle East & Africa Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
• Chapter 7. Company Profiles
  • 7.1. Autonomic Technologies (ATI)
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Baxter Healthcare Corporation
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Bionano Genomics
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Compumedics Limited
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Infraredx, Inc.
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Developments
  • 7.6. Inovio, Pharmaceuticals
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Developments
  • 7.7. Masimo Corporation
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Developments
  • 7.8. Neovasc Inc.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Developments
  • 7.9. Nihon Kohden Corporation, Inc.
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Opioid Use Disorder market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: Opioid Use Disorder market
5. Global Opioid Use Disorder market attractiveness, by Product
6. Global Opioid Use Disorder market attractiveness, by End user
7. Global Opioid Use Disorder market revenue share, by Product, 2024 and 2032
8. Global Opioid Use Disorder market revenue share, by End user, 2024 and 2032
9. Global Opioid Use Disorder market revenue share, by region, 2024 & 2032
10. North America Opioid Use Disorder market, 2024-2032 (USD Billion)
11. Europe Opioid Use Disorder market, 2024-2032 (USD Billion)
12. Asia Pacific Opioid Use Disorder market, 2024-2032 (USD Billion)
13. Latin America Opioid Use Disorder market, 2024-2032 (USD Billion)
14. Middle East & Africa Opioid Use Disorder market, 2024-2032 (USD Billion)
 

Table Of Tables

List of Tables

1. Global Opioid Use Disorder market: snapshot
2. Drivers for Opioid Use Disorder market: impact analysis
3. Restraints for Opioid Use Disorder market: impact analysis
4. North America Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
5. North America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
6. North America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
7. The U.S. Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
8. The U.S. Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
9. Rest of North America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
10. Rest of North America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
11. Europe Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
12. Europe Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
13. Europe Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
14. U.K. Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
15. U.K. Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
16. France Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
17. France Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
18. Germany Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
19. Germany Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
20. Rest of Europe Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
21. Rest of Europe Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
22. Asia Pacific Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
23. Asia Pacific Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
24. Asia Pacific Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
25. China Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
26. China Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
27. Japan Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
28. Japan Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
29. India Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
30. India Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
31. Rest of Asia Pacific Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
32. Rest of Asia Pacific Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
33. Latin America Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
34. Latin America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
35. Latin America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
36. Brazil Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
37. Brazil Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
38. Rest of Latin America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
39. Rest of Latin America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
40. Middle  East & Africa Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
41. Middle  East & Africa Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)